Disruption of Nrf2 signaling impairs angiogenic capacity of endothelial cells: Implications for microvascular aging

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 67 A, Issue 8, 2012, Pages 821-829

  Valcarcel Ares, M Noa ^a,b   Gautam, Tripti ^a   Warrington, Junie P ^a   Bailey Downs, Lora ^a   Sosnowska, Danuta ^a   De Cabo, Rafael ^c   Losonczy, Gyorgy ^d   Sonntag, William E ^a   Ungvari, Zoltan ^a   Csiszar, Anna ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b CHUS   (Spain)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Angiogenesis; Capillary density; Heart; Microcirculation; Vascular aging

Indexed keywords

NFE2L2 PROTEIN, HUMAN; SCLEROPROTEIN; TRANSCRIPTION FACTOR NRF2;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL ADHESION; CELL AGING; CELL MOTION; CELL PROLIFERATION; CORONARY BLOOD VESSEL; CYTOLOGY; ENDOTHELIUM CELL; HUMAN; MICROCIRCULATION; OXIDATIVE STRESS; PHYSIOLOGY;

APOPTOSIS; CELL ADHESION; CELL AGING; CELL MOVEMENT; CELL PROLIFERATION; CORONARY VESSELS; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MICROCIRCULATION; NEOVASCULARIZATION, PHYSIOLOGIC; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS;

EID: 84866346444     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glr229     Document Type: Article

References (83)

1. Afonyushkin T, Oskolkova OV, Philippova M, et al. Oxidized phospholipids regulate expression of ATF4 and VEGF in endothelial cells via NRF2-dependent mechanism: novel point of convergence between electrophilic and unfolded protein stress pathways. Arterioscler Thromb Vasc Biol. 2010; 30: 1007 - 1013.
2. Hosoya T, Maruyama A, Kang MI, et al. Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. J Biol Chem. 2005; 280: 27244 - 27250.
3. Jyrkkanen HK, Kansanen E, Inkala M, et al. Nrf2 regulates antioxidant gene expression evoked by oxidized phospholipids in endothelial cells and murine arteries in vivo. Circ Res. 2008; 103: e1 - e9.
4. Ungvari Z, Bagi Z, Feher A, et al. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am J Physiol Heart Circ Physiol. 2010; 299: H18 - H24.
5. Ungvari ZI, Bailey-Downs L, Gautam T, et al. Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia. Am J Physiol Heart Circ Physiol. 2011; 300: H1133 - H1140.
6. Zakkar M, Van der Heiden K, Luong LA, et al. Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinfl ammatory state. Arterioscler Thromb Vasc Biol. 2009; 29 (11): 1851 - 1857.
7. Dai G, Vaughn S, Zhang Y, Wang ET, Garcia-Cardena G, Gimbrone MA Jr. Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/ Akt-dependent activation of Nrf2. Circ Res. 2007; 101: 723 - 733.
8. Bailey-Downs LC, Mitschelen M, Sosnowska D, et al. Liver-specifi c knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging. J Gerontol A Biol Sci Med Sci. 2011; in press.
9. Ungvari Z, Bailey-Downs L, Gautam T, et al. Age-associated vascular oxidative stress, Nrf2 dysfunction and NF-kB activation in the non-human primate Macaca mulatta. J Gerontol A Biol Sci Med Sci. 2011; 66: 866 - 875.
10. Ungvari Z, Bailey-Downs L, Sosnowska D, et al. Vascular oxidative stress in aging: a homeostatic failure due to dysregulation of Nrf2-mediated antioxidant response. Am J Physiol. 2011; 301: H363 - H372.
11. Collins AR, Lyon CJ, Xia X, et al. Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ Res. 2009; 104: e42 - e54.
12. Gao P, Shen F, Gabriel RA, et al. Attenuation of brain response to vascular endothelial growth factor-mediated angiogenesis and neurogenesis in aged mice. Stroke. 2009; 40: 3596 - 3600.
13. Kitlinska J, Lee EW, Movafagh S, Pons J, Zukowska Z. Neuropeptide Y-induced angiogenesis in aging. Peptides. 2002; 23: 71 - 77.
14. Bach MH, Sadoun E, Reed MJ. Defects in activation of nitric oxide synthases occur during delayed angiogenesis in aging. Mech Ageing Dev. 2005; 126: 467 - 473.
15. Facchetti F, Monzani E, Cavallini G, Bergamini E, La Porta CA. Effect of a caloric restriction regimen on the angiogenic capacity of aorta and on the expression of endothelin-1 during ageing. Exp Gerontol. 2007; 42: 662 - 667.
16. Iemitsu M, Maeda S, Jesmin S, Otsuki T, Miyauchi T. Exercise training improves aging-induced downregulation of VEGF angiogenic signaling cascade in hearts. Am J Physiol Heart Circ Physiol. 2006; 291: H1290 - H1298.
17. Jozsi AC, Dupont-Versteegden EE, Taylor-Jones JM, et al. Aged human muscle demonstrates an altered gene expression profi le consistent with an impaired response to exercise. Mech Ageing Dev. 2000; 120: 45 - 56.
18. Rivard A, Berthou-Soulie L, Principe N, et al. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem. 2000; 275: 29643 - 29647.
19. Rivard A, Fabre JE, Silver M, et al. Age-dependent impairment of angiogenesis. Circulation. 1999; 99: 111 - 120.
20. Sadoun E, Reed MJ. Impaired angiogenesis in aging is associated with alterations in vessel density, matrix composition, infl ammatory response, and growth factor expression. J Histochem Cytochem. 2003; 51: 1119 - 1130.
21. Ungvari Z, Kaley G, de Cabo R, Sonntag WE, Csiszar A. Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci. 2010; 65: 1028 - 1041.
22. Ungvari Z, Labinskyy N, Mukhopadhyay P, et al. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol. 2009; 297: H1876 - H1881.
23. Csiszar A, Ahmad M, Smith KE, et al. Bone morphogenetic protein-2 induces proinfl ammatory endothelial phenotype. Am J Pathol. 2006; 168: 629 - 638.
24. Csiszar A, Labinskyy N, Jimenez R, et al. Anti-oxidative and antiinfl ammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT1. Mech Ageing Dev. 2009; 130: 518 - 527.
25. Csiszar A, Labinskyy N, Podlutsky A, et al. Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. Am J Physiol Heart Circ Physiol. 2008; 294: H2721 - H2735.
26. Clapp C, Thebault S, Jeziorski MC, Martinez De La Escalera G. Peptide hormone regulation of angiogenesis. Physiol Rev. 2009; 89: 1177 - 1215.
27. Csiszar A, Labinskyy N, Smith K, Rivera A, Orosz Z, Ungvari Z. Vasculoprotective effects of anti-TNFalfa treatment in aging. Am J Pathol. 2007; 170: 388 - 698.
28. Pepe M, Mamdani M, Zentilin L, et al. Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy. Circ Res. 2010; 106: 1893 - 1903.
29. Ungvari Z, Ridgway I, Philipp EE, et al. Extreme longevity is associated with increased resistance to oxidative stress in Arctica islandica, the longest-living non-colonial animal. J Gerontol A Biol Sci Med Sci. 2011; 66 (7): 741 - 750.
30. Ungvari Z, Sosnowska D, Podlutsky A, Koncz P, Sonntag WE, Csiszar A. Free radical production, antioxidant capacity, and oxidative stress response signatures in fi broblasts from Lewis dwarf rats: effects of life span-extending peripubertal GH treatment. J Gerontol A Biol Sci Med Sci. 2011; 66 (5): 501 - 510.
31. Csiszar A, Labinskyy N, Zhao X, et al. Vascular superoxide and hydrogen peroxide production and oxidative stress resistance in two closely related rodent species with disparate longevity. Aging Cell. 2007; 6: 783 - 797.
32. Labinskyy N, Mukhopadhyay P, Toth J, et al. Longevity is associated with increased vascular resistance to high glucose-induced oxidative stress and infl ammatory gene expression in Peromyscus leucopus. Am J Physiol Heart Circ Physiol. 2009; 296: H946 - H956.
33. Behrens MI, Silva M, Schmied A, et al. Age-dependent increases in apoptosis/necrosis ratios in human lymphocytes exposed to oxidative stress. J Gerontol A Biol Sci Med Sci. 2011; 66: 732 - 740.
34. Campisi J, Vijg J. Does damage to DNA and other macromolecules play a role in aging? If so, how? J Gerontol A Biol Sci Med Sci. 2009; 64: 175 - 178.
35. Dekker P, de Lange MJ, Dirks RW, et al. Relation between maximum replicative capacity and oxidative stress-induced responses in human skin fi broblasts in vitro. J Gerontol A Biol Sci Med Sci. 2011; 66: 45 - 50.
36. Forman K, Vara E, Garcia C, et al. Effect of a combined treatment with growth hormone and melatonin in the cardiological aging on male SAMP8 mice. J Gerontol A Biol Sci Med Sci. 2011; 66: 823 - 834.
37. Kakarla SK, Rice KM, Katta A, et al. Possible molecular mechanisms underlying age-related cardiomyocyte apoptosis in the F344XBN rat heart. J Gerontol A Biol Sci Med Sci. 2010; 65: 147 - 155.
38. Miller RA. Cell stress and aging: new emphasis on multiplex resistance mechanisms. J Gerontol A Biol Sci Med Sci. 2009; 64: 179 - 182.
39. Csiszar A, Podlutsky A, Podlutskaya N, et al. Testing the oxidative stress hypothesis of aging in primate fi broblasts: is there a correlation between species longevity and cellular ROS production? J Gerontol A Biol Sci Med Sci. 2011; in press.
40. West XZ, Malinin NL, Merkulova AA, et al. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature. 2010; 467: 972 - 976.
41. Ushio-Fukai M, Nakamura Y. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett. 2008; 266: 37 - 52.
42. Handayaningsih AE, Iguchi G, Fukuoka H, et al. Reactive oxygen species play an essential role in IGF-I signaling and IGF-I-induced myocyte hypertrophy in C2C12 myocytes. Endocrinology. 2011; 152: 912 - 921.
43. Abid MR, Kachra Z, Spokes KC, Aird WC. NADPH oxidase activity is required for endothelial cell proliferation and migration. FEBS Lett. 2000; 486: 252 - 256.
44. Abid MR, Spokes KC, Shih SC, Aird WC. NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways. J Biol Chem. 2007; 282: 35373 - 35385.
45. Yamaoka-Tojo M, Ushio-Fukai M, Hilenski L, et al. IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species - dependent endothelial migration and proliferation. Circ Res. 2004; 95: 276 - 283.
46. Tojo T, Ushio-Fukai M, Yamaoka-Tojo M, Ikeda S, Patrushev N, Alexander RW. Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation. 2005; 111: 2347 - 2355.
47. Colavitti R, Pani G, Bedogni B, et al. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem. 2002; 277: 3101 - 3108.
48. Lin MT, Yen ML, Lin CY, Kuo ML. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol Pharmacol. 2003; 64: 1029 - 1036.
49. Papaiahgari S, Zhang Q, Kleeberger SR, Cho HY, Reddy SP. Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-PI3KAkt/ ERK MAP kinase signaling in pulmonary epithelial cells. Antioxid Redox Signal. 2006; 8: 43 - 52.
50. Beyer TA, Xu W, Teupser D, et al. Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistance. EMBO J. 2008; 27: 212 - 223.
51. Loboda A, Stachurska A, Florczyk U, et al. HIF-1 induction attenuates Nrf2-dependent IL-8 expression in human endothelial cells. Antioxid Redox Signal. 2009; 11: 1501 - 1517.
52. Uno K, Prow TW, Bhutto IA, et al. Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy. Exp Eye Res. 2010; 90: 493 - 500.
53. Kim TH, Hur EG, Kang SJ, et al. NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1{alpha}. Cancer Res. 2011; 71 (6): 2260 - 2275.
54. Deramaudt BM, Braunstein S, Remy P, Abraham NG. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem. 1998; 68: 121 - 127.
55. Grochot-Przeczek A, Dulak J, Jozkowicz A. Heme oxygenase-1 in neovascularisation: a diabetic perspective. Thromb Haemost. 2010; 104: 424 - 431.
56. Samuel SM, Thirunavukkarasu M, Penumathsa SV, et al. Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats. Circulation. 2010; 121: 1244 - 1255.
57. Jodar L, Mercken EM, Ariza J, et al. Genetic deletion of nrf2 promotes immortalization and decreases life span of murine embryonic fi broblasts. J Gerontol A Biol Sci Med Sci. 2011; 66: 247 - 256.
58. Okouchi M, Okayama N, Alexander JS, Aw TY. NRF2-dependent glutamate-L-cysteine ligase catalytic subunit expression mediates insulin protection against hyperglycemia- induced brain endothelial cell apoptosis. Curr Neurovasc Res. 2006; 3: 249 - 261.
59. Morito N, Yoh K, Itoh K, et al. Nrf2 regulates the sensitivity of death receptor signals by affecting intracellular glutathione levels. Oncogene. 2003; 22: 9275 - 9281.
60. Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley G. Proinfl ammatory phenotype of coronary arteries promotes endothelial apoptosis in aging. Physiol Genomics. 2004; 17: 21 - 30.
61. Anversa P, Li P, Sonnenblick EH, Olivetti G. Effects of aging on quantitative structural properties of coronary vasculature and microvasculature in rats. Am J Physiol. 1994; 267: H1062 - H1073.
62. Riddle DR, Sonntag WE, Lichtenwalner RJ. Microvascular plasticity in aging. Ageing Res Rev. 2003; 2: 149 - 168.
63. Sonntag WE, Lynch CD, Cooney PT, Hutchins PM. Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor 1. Endocrinology. 1997; 138: 3515 - 3520.
64. Phillips GD, Stone AM. PDGF-BB induced chemotaxis is impaired in aged capillary endothelial cells. Mech Ageing Dev. 1994; 73: 189 - 196.
65. Benndorf RA, Schwedhelm E, Gnann A, et al. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis. Circ Res. 2008; 103: 1037 - 1046.
66. Khurana R, Simons M, Martin JF, Zachary IC. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation. 2005; 112: 1813 - 1824.
67. Pislaru SV, Simari RD. Gene transfer for ischemic cardiovascular disease: is this the end of the beginning or the beginning of the end? Nat Clin Pract Cardiovasc Med. 2005; 2: 138 - 144.
68. Henry TD, Annex BH, McKendall GR, et al. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation. 2003; 107: 1359 - 1365.
69. Simons M, Annex BH, Laham RJ, et al. Pharmacological treatment of coronary artery disease with recombinant fi broblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation. 2002; 105: 788 - 793.
70. Grines CL, Watkins MW, Helmer G, et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation. 2002; 105: 1291 - 1297.
71. Kastrup J, Jorgensen E, Ruck A, et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris. A randomized double-blind placebocontrolled study: the Euroinject One trial. J Am Coll Cardiol. 2005; 45: 982 - 988.
72. Belleri M, Ribatti D, Nicoli S, et al. Antiangiogenic and vasculartargeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. Mol Pharmacol. 2005; 67: 1451 - 1459.
73. Fukuda S, Kaga S, Zhan L, et al. Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1. Cell Biochem Biophys. 2006; 44: 43 - 49.
74. Oomen CA, Farkas E, Roman V, van der Beek EM, Luiten PG, Meerlo P. Resveratrol preserves cerebrovascular density and cognitive function in aging mice. Front Aging Neurosci. 2009; 1: 4.
75. Pearson KJ, Baur JA, Lewis KN, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 2008; 8: 157 - 168.
76. Ungvari Z, Orosz Z, Rivera A, et al. Resveratrol increases vascular oxidative stress resistance. Am J Physiol. 2007; 292: H2417 - H2424.
77. Chandrashekara KT, Shakarad MN. Aloe vera or resveratrol supplementation in larval diet delays adult aging in the fruit fl y, Drosophila melanogaster. J Gerontol A Biol Sci Med Sci. 2011; 66: 965 - 971.
78. Giovannelli L, Pitozzi V, Jacomelli M, et al. Protective effects of resveratrol against senescence-associated changes in cultured human fi broblasts. J Gerontol A Biol Sci Med Sci. 2011; 66: 9 - 18.
79. Jackson JR, Ryan MJ, Alway SE. Long-term supplementation with resveratrol alleviates oxidative stress but does not attenuate sarcopenia in aged mice. J Gerontol A Biol Sci Med Sci. 2011; 66: 751 - 764.
80. Labbe A, Garand C, Cogger VC, et al. Resveratrol improves insulin resistance hyperglycemia and hepatosteatosis but not hypertriglyceridemia, infl ammation, and life span in a mouse model for werner syndrome. J Gerontol A Biol Sci Med Sci. 2011; 66: 264 - 278.
81. Ryan MJ, Jackson JR, Hao Y, et al. Suppression of oxidative stress by resveratrol after isometric contractions in gastrocnemius muscles of aged mice. J Gerontol A Biol Sci Med Sci. 2010; 65: 815 - 831.
82. Smoliga JM, Vang O, Baur JA. Challenges of translating basic research into therapeutics: resveratrol as an example. J Gerontol A Biol Sci Med Sci. 2011; doi:10.1093/gerona/glr164.
83. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006; 444: 337 - 342.